Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 129 results.
User Information
Export Records
  1. 1.   Adoptive lymphocyte transfer to an HIV-infected progressor from an elite controller
  2. Migueles, Stephen A.; Chairez, Cheryl; Lin, Siying; Cavil, Noah; Rosenthal, Danielle M.; Pooran, Milad; Natarajan,Ven; Rupert,Adam; Dewar,Robin; Rehman, Tauseef; Sherman,Brad; Adelsberger,Joe; Leitman, Susan F.; Stroncek, David; Morse, Caryn G.; Connors, Mark; Lane, H. Clifford; Kovacs, Joseph A.
  3. JCI INSIGHT. 2019, SEP 19; 4(18):
  1. 2.   GATA2-deficient mast cells limit IgE-mediated immediate hypersensitivity reactions in humans
  2. Desai, Avanti; Sowerwine, Kathryn; Liu, Yihui; Lawrence, Monica G; Chovanec, Jack; Hsu, Amy P; O'Connell, Michael P; Kim, Jiwon; Boris, Lisa; Jones,Nina; Wisch, Laura; Eisch, Robin R; Carter, Melody C; Komarow, Hirsh D; Zerbe, Christa; Milner, Joshua D; Maric, Irina; Sun, Xiaoping; Lee, Chyi-Chia R; Tunc, Ilker; Pirooznia, Mehdi; Stone, Kelly D; Holland, Steven M; Metcalfe, Dean D; Lyons, Jonathan J
  3. The Journal of allergy and clinical immunology. 2019, AUG; 144(2): 613-+.
  1. 3.   CD19-positive antibody-secreting cells provide immune memory
  2. Groves, C. J.; Carrell, Jeff; Grady, R.; Rajan, B.; Morehouse, C. A.; Halpin, R.; Wang, J.; Wu, J.; Shrestha, Y.; Rayanki, R.; Kolbeck, R.; Wang, Y.; Herbst, R.
  3. Blood advances. 2018, NOV 27; 2(22): 3163-3176.
  1. 4.   Glucose-induced increase in circulating progenitor cells is blunted in polycystic amenorrhoeic subjects
  2. Bairagi, S.; Gopal, J.; Nathan, A. A.; Babu, S. S.; Kumar, N. P.; Dixit, M.
  3. Human Reproduction. 2012, Mar; 27(3): 844-853.
  1. 5.   Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells
  2. He, S.; Wang, J. N.; Kato, K.; Xie, F.; Varambally, S.; Mineishi, S.; Kuick, R.; Mochizuki, K.; Liu, Y. N. A.; Nieves, E.; Mani, R. S.; Chinnaiyan, A. M.; Marquez, V. E.; Zhang, Y.
  3. Blood. 2012, Feb; 119(5): 1274-1282.
  1. 6.   PUMILIO-2 Is Involved in the Positive Regulation of Cellular Proliferation in Human Adipose-Derived Stem Cells
  2. Shigunov, P.; Sotelo-Silveira, J.; Kuligovski, C.; de Aguiar, A. M.; Rebelatto, C. K.; Moutinho, J. A.; Brofman, P. S.; Krieger, M. A.; Goldenberg, S.; Munroe, D.; Correa, A.; Dallagiovanna, B.
  3. Stem Cells and Development. 2012, Jan; 21(2): 217-227.
  1. 7.   The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome
  2. McDermott, D. H.; Liu, Q.; Ulrick, J.; Kwatemaa, N.; Anaya-O'Brien, S.; Penzak, S. R.; Oliveira, J.; Priel, D. A. L.; Kelly, C.; Garofalo, M.; Littel, P.; Marquesen, M. M.; Hilligoss, D.; DeCastro, R.; Fleisher, T. A.; Kuhns, D. B.; Malech, H. L.; Murphy, P. M.
  3. Blood. 2011, Nov; 118(18): 4957-4962.
  1. 8.   Mouse Ly49G2(+) NK cells dominate early responses during both immune reconstitution and activation independently of MHC
  2. Barao, I.; Alvarez, M.; Ames, E.; Orr, M. T.; Stefanski, H. E.; Blazar, B. R.; Lanier, L. L.; Anderson, S. K.; Redelman, D.; Murphy, W. J.
  3. Blood. 2011, Jun; 117(26): 7032-7041.
  1. 9.   Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
  2. Buhtoiarov, I. N.; Sondel, P. M.; Wigginton, J. M.; Buhtoiarova, T. N.; Yanke, E. M.; Mahvi, D. A.; Rakhmilevich, A. L.
  3. Immunology. 2011, Feb; 132(2): 226-239.
  1. 10.   Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
  2. Shusterman, S.; London, W. B.; Gillies, S. D.; Hank, J. A.; Voss, S. D.; Seeger, R. C.; Reynolds, C. P.; Kimball, J.; Albertini, M. R.; Wagner, B.; Gan, J.; Eickhoff, J.; DeSantes, K. B.; Cohn, S. L.; Hecht, T.; Gadbaw, B.; Reisfeld, R. A.; Maris, J. M.; Sondel, P. M.
  3. Journal of Clinical Oncology. 2010, Nov; 28(33): 4969-4975.
  1. 11.   Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis
  2. McDermott, D. H.; De Ravin, S. S.; Jun, H. S.; Liu, Q. A.; Priel, D. A. L.; Noel, P.; Takemoto, C. M.; Ojode, T.; Paul, S. M.; Dunsmore, K. P.; Hilligoss, D.; Marquesen, M.; Ulrick, J.; Kuhns, D. B.; Chou, J. Y.; Malech, H. L.; Murphy, P. M.
  3. Blood. 2010, Oct; 116(15): 2793-2802.
  1. 12.   Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia
  2. Vinh, D. C.; Patel, S. Y.; Uzel, G.; Anderson, V. L.; Freeman, A. F.; Olivier, K. N.; Spalding, C.; Hughes, S.; Pittaluga, S.; Raffeld, M.; Sorbara, L. R.; Elloumi, H. Z.; Kuhns, D. B.; Turner, M. L.; Cowen, E. W.; Fink, D.; Long-Priel, D.; Hsu, A. P.; Ding, L.; Paulson, M. L.; Whitney, A. R.; Sampaio, E. P.; Frucht, D. M.; Deleo, F. R.; Holland, S. M.
  3. Blood. 2010, Feb; 115(8): 1519-1529.
  1. 13.   Stem cells as a therapeutic target for diabetes
  2. Mishra, P. K.; Singh, S. R.; Joshua, I. G.; Tyagi, S. C.
  3. Frontiers in Bioscience-Landmark. 2010, Jan; 15: 461-477.
  1. 14.   JS-K has potent anti-angiogenic activity in vitro and inhibits tumour angiogenesis in a multiple myeloma model in vivo
  2. Kiziltepe, T.; Anderson, K. C.; Kutok, J. L.; Jia, L.; Boucher, K. M.; Saavedra, J. E.; Keefer, L. K.; Shami, P. J.
  3. Journal of Pharmacy and Pharmacology. 2010, Jan; 62(1): 145-151.
  1. 15.   EARLY T LYMPHOCYTES Differentiation In Vivo of Adult Intrathymic Precursor Cells (Reprinted from Experimental Medicine, vol 162, pg 802-822, 1985)
  2. Fowlkes, B. J.; Edison, L.; Mathieson, B. J.; Chused, T. M.
  3. Journal of Immunology. 2009, Jul; 183(1): 5-25.
  1. 16.   Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vector-transduced CD34(+) cells
  2. Kim, Y. J.; Kim, Y. S.; Larochelle, A.; Renaud, G.; Wolfsberg, T. G.; Adler, R.; Donahue, R. E.; Hematti, P.; Hong, B. K.; Roayaei, J.; Akagi, K.; Riberdy, J. M.; Nienhuis, A. W.; Dunbar, C. E.; Persons, D. A.
  3. Blood. 2009 113(22): 5434-5443.
  1. 17.   Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature
  2. Klarmann, G. J.; Hurt, E. M.; Mathews, L. A.; Zhang, X. H.; Duhagon, M. A.; Mistree, T.; Thomas, S. B.; Farrar, W. L.
  3. Clinical & Experimental Metastasis. 2009 26(5): 433-446.
  1. 18.   Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras
  2. Lauchle, J. O.; Kim, D.; Le, D. T.; Akagi, K.; Crone, M.; Krisman, K.; Warner, K.; Bonifas, J. M.; Li, Q.; Coakley, K. M.; Diaz-Flores, E.; Gorman, M.; Przybranowski, S.; Tran, M.; Kogan, S. C.; Roose, J. P.; Copeland, N. G.; Jenkins, N. A.
  3. Nature. 2009 461(7262): 411-U110.
  1. 19.   Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
  2. Barkan, D.; Kleinman, H.; Simmons, J. L.; Asmussen, H.; Kamaraju, A. K.; Hoenorhoff, M. J.; Liu, Z. Y.; Costes, S. V.; Cho, E. H.; Lockett, S.; Khanna, C.; Chambers, A. F.; Green, J. E.
  3. Cancer Research. 2008 68(15): 6241-6250.
  1. 20.   Availability of activated CD4(+) T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys
  2. Klatt, N. R.; Villinger, F.; Bostik, P.; Gordon, S. N.; Pereira, L.; Engram, J. C.; Mayne, A.; Dunham, R. M.; Lawson, B.; Ratcliffe, S. J.; Sodora, D. L.; Else, J.; Reimann, K.; Staprans, S. I.; Haase, A. T.; Estes, J. D.; Silvestri, G.; Ansari, A. A.
  3. Journal of Clinical Investigation. 2008 118(6): 2039-2049.
  1. 21.   Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells
  2. Laffont, S.; Seillet, C.; Ortaldo, J.; Coudert, J. D.; Guery, J. C.
  3. Blood. 2008 112(3): 661-671.
  1. 22.   The role of p202 in regulating hematopoietic cell proliferation and differentiation
  2. Ludlow, L. E.; Purton, L. E.; Klarmann, K.; Gough, D. J.; Hii, L. L.; Trapani, J. A.; Keller, J. R.; Clarke, C.; Johnstone, R. W.
  3. Journal of Interferon and Cytokine Research. 2008 28(1): 5-11.
  1. 23.   A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
  2. Mackall, C. L.; Rhee, E. H.; Read, E. J.; Khuu, H. M.; Leitman, S. F.; Bernstein, D.; Tesso, M.; Long, L. M.; Grindler, D.; Merino, M.; Kopp, W.; Tsokos, M.; Berzofsky, J. A.; Helman, L. J.
  3. Clinical Cancer Research. 2008 14(15): 4850-4858.
  1. 24.   An inducible and reversible mouse genetic rescue system
  2. Zeng, H. K.; Horie, K.; Madisen, L.; Pavlova, M. N.; Gragerova, G.; Rohde, A. D.; Schimpf, B. A.; Liang, Y. Q.; Ojala, E.; Kramer, F.; Roth, P.; Slobodskaya, O.; Dolka, I.; Southon, E. A.; Tessarollo, L.; Bornfeldt, K. E.; Gragerov, A.; Pavlakis, G.
  3. Plos Genetics. 2008 4(5): 1-13.
  1. 25.   NF-kappa B p50/p65 affects the frequency of Ly49 gene expression by NK Cells
  2. Pascal, V.; Nathan, N. R.; Claudio, E.; Siebenlist, U.; Anderson, S. K.
  3. Journal of Immunology. 2007, Aug; 179(3): 1751-1759.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel